Engflag

Powerman

Quick links to important sections

Powerman

Powerman_EN

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Powerman

Here is a quick overview of the essential characteristics of the medicinal product Powerman, defined by its composition and scientific classification.

Property Description
Active Ingredient Sildenafil (Sildenafil citrate)
Form Tablet (Solid oral formulation)
Pharmacological Class Phosphodiesterase Type 5 (PDE5) Inhibitor
Origin Synthetic compound

The Definitive Identity of Powerman and its Composition

Powerman is an oral, prescription-only pharmaceutical preparation whose single active component is Sildenafil, a chemically distinct synthetic compound often formulated as Sildenafil citrate. As an oral therapeutic agent, it is delivered in the form of a solid oral tablet, consisting of the active compound and necessary solid excipients for precise systemic administration. This identity establishes the medicine as a strictly controlled chemical entity, distinguishing it from combination or naturally derived products.

Pharmacological Classification and General Action

The authoritative scientific classification for Powerman is the Phosphodiesterase Type 5 (PDE5) Inhibitor class. This mechanism is characterized by its high degree of specificity, acting as a selective inhibitor that temporarily blocks the PDE5 enzyme, which naturally regulates blood flow in specific vascular tissues.

The core benefit derived from this mechanism is the enhancement of the body's ability to achieve smooth muscle relaxation in blood vessel walls, consequently facilitating an increase in localized blood flow. Sildenafil, by selectively blocking the PDE5 enzyme, serves as a primary pharmacological option for optimizing the vascular response when needed. This selective action ensures the drug’s utility is focused on improving circulation in targeted areas, such as during the treatment of conditions related to inadequate localized circulation.

Regulatory References

  1. NIH Drug Information on Sildenafil Citrate

What side effects are possible with Powerman?

Official Safety Profile and Adverse Reactions

The safety profile of Powerman (Sildenafil) is classified by regulatory authorities into frequency categories based on clinical and post-marketing data. The most frequently observed adverse reactions are linked to the drug's vasodilatory properties.

Frequency-Classified Adverse Reactions

The following are examples of adverse reactions grouped by frequency, as documented in official prescribing information:

  • Very Common (ge 1/10): Headache and Flushing.
  • Common (ge 1/100 to < 1/10): Dizziness, Dyspepsia (indigestion), Nasal congestion, and visual disturbances, such as blurred vision or visual color distortions.
  • Uncommon to Rare (le 1/1000): Effects on various systems, including rash, myalgia (muscle pain), palpitations, and tinnitus (ringing in the ears).

Serious Adverse Reactions and Safety Constraints

Official regulatory labels emphasize the potential for rare but serious adverse reactions and define strict safety limitations. Serious adverse reactions that have been documented include Priapism (an erection lasting longer than four to six hours) and sudden Non-arteritic anterior ischemic optic neuropathy (NAION), a cause of sudden vision loss. Serious cardiovascular events, such as Myocardial Infarction and Stroke, have been reported in the post-marketing setting.

Powerman is contraindicated for use with any form of organic nitrates or nitric oxide donors due to the high risk of severe, life-threatening hypotension. Caution is also advised in patients with pre-existing cardiovascular disease or conditions that predispose them to priapism, and for those with severe hepatic or renal impairment.

Overdose and Emergency Response

A Powerman overdose, resulting from high systemic exposure, is officially documented as presenting with an increased rate and severity of adverse reactions. The clinical signs associated with high exposure include decreased blood pressure (hypotension), syncope, and a prolonged erection.

Immediate medical assistance is required for severe manifestations, as explicitly mandated by regulatory authorities. Any erection that persists for longer than four hours is classified as a severe event (Priapism) and necessitates immediate medical assistance to prevent permanent damage. Furthermore, patients must consult a physician immediately upon experiencing any sudden visual defect or sudden loss of sight or hearing, as these are critical outcomes that demand prompt attention.

Official guidance for overdose management is limited to general symptomatic and supportive measures. Regulatory documents specify that no specific antidote is known for Sildenafil overdose. The risk of high-exposure manifestations is noted to be higher in patients with severe renal or hepatic impairment due to reduced clearance, and in those taking strong CYP3A4 inhibitors. The product's characteristics indicate that haemodialysis is not expected to accelerate clearance.

Therapeutic Uses of Powerman

Powerman (Sildenafil) is therapeutically focused on conditions where localized blood flow or vascular resistance is the primary symptomatic driver, providing relief across two key domains.

The medication is commonly used for managing the symptomatic patterns of Impaired Erectile Function and Pulmonary Arterial Hypertension (PAH). It is applied across domains where additional symptomatic support is needed to address symptoms that create noticeable physiological strain, such as the inability to maintain an erection or the shortness of breath and fatigue associated with high lung artery pressure.

In clinical settings, this supportive relief contributes to easing the overall symptom load during periods of heightened symptoms when symptoms interfere with routine activities. It is considered relevant for easing symptoms related to systemic imbalance and may assist with maintaining functional stability by supporting improved physical stamina, generally helping to address groups of symptoms that may become intense or disruptive.

Quick Fact: Relief for Vascular Functional Strain Powerman is commonly used in conditions characterized by periods of heightened symptoms where the primary clinical presentation is insufficient localized circulation or high vascular resistance in the lungs.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Powerman (Sildenafil) is intended for use in adult men for Erectile Dysfunction and adults and pediatric patients (aged 1–17) for Pulmonary Arterial Hypertension (PAH), as documented in official regulatory labels. However, its chronic use in children with PAH is not recommended due to clinical trial findings of increased mortality with rising doses.

Absolute Contraindications (Must Not Use)

Powerman is strictly contraindicated in several populations due to unacceptable risk, including:

  • Patients taking organic nitrates or the guanylate cyclase stimulator riociguat.
  • Individuals with known hypersensitivity to Sildenafil or its components.
  • Patients with a history of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) or specific hereditary retinal disorders.
  • Patients with severe cardiovascular conditions (e.g., recent stroke or myocardial infarction within six months, or severe cardiac failure) or severe hypotension (BP le 90/50 mmHg).

Conditional Use and Restrictions

Use requires caution or restriction in specific patient groups:

Population Group Regulatory Constraint
Severe Hepatic Impairment Contraindicated for ED use; clearance is reduced in mild/moderate impairment.
Severe Renal Impairment Reduced clearance is observed, requiring special consideration.
Specific Conditions Caution required in patients prone to priapism (e.g., sickle cell anaemia) or those with anatomical deformation of the penis (e.g., Peyronie's disease).
Women Not indicated for the treatment of Erectile Dysfunction.

For pregnancy and lactation, regulatory documents note that no adequate and well-controlled studies exist, necessitating a careful risk assessment, particularly in PAH.

What should I know about interactions with other medicines?

Powerman Interactions with other medicines and products

This section outlines the official interaction information for Powerman (Sildenafil), derived from government regulatory documents.

Interaction Classifications (High-Level)

Interaction Severity Regulatory Classification
Contraindicated Use with organic nitrates or Riociguat (guanylate cyclase stimulator) [1.1, 1.9, 2.1].
Use Not Recommended Use with other PDE5 Inhibitors or potent CYP3A4 inhibitors (e.g., Ritonavir) [1.7, 1.9].

Official Interaction Statements

  • Contraindicated Combinations: Co-administration with organic nitrates (in any form) or the guanylate cyclase stimulator Riociguat is formally prohibited due to the risk of severe, additive hypotensive effects [1.1, 2.1].
  • Metabolic Interactions: Sildenafil is cleared predominantly via the CYP3A4 enzyme system [1.10]. Strong CYP3A4 inhibitors (e.g., Ketoconazole, Erythromycin) decrease Sildenafil clearance, resulting in increased systemic exposure [1.7]. Conversely, CYP3A4 inducers (e.g., Rifampin) decrease exposure [2.4].
  • Pharmacodynamic Effects: Co-administration with alpha-blockers or other anti-hypertensives may result in an additive blood pressure-lowering effect [1.7, 2.2]. For alpha-blocker co-administration, patients should be stable on alpha-blocker therapy prior to Sildenafil initiation [2.1].
  • Population-Specific Notes: Reduced drug clearance, leading to increased exposure (AUC and Cmax), is documented in patients with hepatic impairment or severe renal impairment [1.7, 2.1].

The regulatory interaction profile is defined by both pharmacodynamic prohibitions, based on the risk of profound additive vasodilation, and pharmacokinetic constraints, which govern how other substances alter Sildenafil's metabolic clearance via the CYP3A4 enzyme system. This structured approach informs the official restrictions on co-administration with multiple drug classes.

Mechanism of Action

How Powerman Works

The mechanism of action of Powerman (Sildenafil) is rooted in the targeted modulation of a critical enzyme-mediated signaling cascade, which potentiates the body's natural response to localized stimuli.

Enzyme Blockade for cGMP Stabilization

This domain describes the drug's action as a selective competitive inhibitor of the enzyme Phosphodiesterase Type 5 (PDE5), which is responsible for degrading the signaling molecule cGMP. By blocking this degradation, the drug ensures that cGMP levels increase and persist within the smooth muscle cells. The resulting molecular action contributes to sustaining the physiological signal for smooth muscle relaxation.

NO Pathway Amplification and Vascular Tone Modulation

The mechanism operates within the established Nitric Oxide (NO)-cGMP signaling pathway. The drug does not initiate the process but acts as an amplifier, strengthening the endogenous NO signal. The cascade results in the activation of Protein Kinase G (PKG), which reduces intracellular calcium and causes vascular smooth muscle relaxation, leading to reduced vascular resistance and augmented local blood volume. This amplification is stimulus-dependent and constitutes the central physiological outcome of the mechanism.

Dosage and Administration Information

The official use of Powerman (Sildenafil) is defined by two separate, indication-specific administration protocols for its oral tablet form.

Official Administration Guidelines

Element Impaired Erectile Function (IEF) Pulmonary Arterial Hypertension (PAH)
Route of Administration Oral administration of tablet. Oral administration of tablet.
Dosing Rules Starting dose: 50 mg. Max single dose: 100 mg. Range: 25 mg to 100 mg. Recommended dose: 20 mg. Titration max: 80 mg per dose.
Frequency and Timing Once per day maximum; taken 30 minutes to 4 hours prior to activity. Three times a day (TID); doses separated by 4 to 6 hours.
Timing in Relation to Meals May be taken with or without food. Administered based on 4 to 6 hour interval.

Special Administration Conditions

These official instructions require dose adjustments in specific patient contexts. For the IEF regimen, a starting dose of 25 mg should be considered for older adults, individuals with severe renal impairment, or those with hepatic impairment. Furthermore, when used concurrently with potent CYP3A4 inhibitors (e.g., ritonavir), the IEF dose must be reduced to a maximum of 25 mg within a 48-hour period. The PAH regimen, conversely, is a continuous, long-term therapy, requiring consistent adherence to the TID schedule to maintain systemic concentration.

Recent Clinical Evidence

Powerman: Recent Clinical Evidence

Evidence for use in Impaired Erectile Function

Research studied Powerman for Impaired Erectile Function, focusing on patient-reported outcomes related to daily functioning. The evidence primarily comes from short-term (4-24 weeks) Randomized, Double-Blind, Placebo-Controlled Trials (RCTs). Specific tools, such as the International Index of Erectile Function (IIEF), were used to measure changes. In these research contexts, data show patterns related to the percentage of successful sexual attempts recorded in the active-treatment groups. Research highlights changes measured during the study period in scores on patient questionnaires.

Evidence for use in Pulmonary Arterial Hypertension

Powerman was studied for use in Pulmonary Arterial Hypertension (PAH), a condition associated with functional limitations. The initial evidence base is centered on short-term (12-16 weeks) Randomized, Double-Blind, Placebo-Controlled Trials (RCTs). Researchers primarily examined changes in exercise capacity, most often by measuring the 6-minute walk distance (6MWD), and monitored changes in the patient's WHO Functional Class. Findings describe patterns observed in the studies where patients receiving the study drug were monitored for changes in their 6MWD measurements over the initial study period.

Long-term Studies and Evidence Gaps

Evidence concerning the sustained use of Powerman for both indications over multiple years is limited. While pivotal trials were short-term, data are available from open-label extension studies where patients continued treatment for longer periods. These extension studies primarily monitored patterns of long-term use, but the long-term effects are not fully established by controlled evidence. Data for certain groups remain insufficient, particularly for patients with recent, severe cardiovascular events. In PAH, research has not yet fully characterized long-term outcomes related to survival or disease progression.

Evidence in Special Populations

The initial research for Impaired Erectile Function included adult men across a wide age range and subgroups with comorbidities such as diabetes. For the pediatric population with PAH, research has explored its use, but findings were mixed, and data are still emerging for this specific group, meaning certainty remains low.

Key Studies & References

  1. Sildenafil (Oral Route)
  2. The discovery and development of sildenafil and its functional effects on human corpus cavernosum and coronary artery

Frequently Asked Questions (FAQ)

Common questions about Powerman (FAQ)

Q: Is Powerman the same type of medicine as [similar drug name]?

Powerman's active ingredient, Sildenafil, is classified by regulatory bodies as a Phosphodiesterase Type 5 (PDE5) Inhibitor. Medicines in this class share the same fundamental mechanism of action by selectively blocking the PDE5 enzyme. Other PDE5 inhibitors are distinct compounds, each with its own specific characteristics and regulatory guidelines.

Q: Does Powerman cause weight gain or weight loss?

Regulatory safety documents state that increased weight and fluid retention are listed as Common side effects (occurring in 1% to 10% of patients) during clinical trials for the PAH indication. Information regarding weight loss as an adverse reaction is not typically featured in the official safety documents.

Q: What should I do if I miss a dose of Powerman?

If a dose for the chronic Pulmonary Arterial Hypertension (PAH) regimen is missed, regulatory instructions advise taking it as soon as it is remembered, unless it is nearly time for the next scheduled dose. If so, the regulatory guidance is to typically skip the missed dose and resume the schedule at the usual time. The Impaired Erectile Function (IEF) regimen is taken only as needed, so a dose is not considered 'missed.'

Q: What are the common side effects of Powerman?

According to the official product information, the most frequently observed side effects are Headache and Flushing (classified as Very Common). Other effects classified as Common include Dizziness, Dyspepsia (indigestion), Nasal congestion, and changes in vision, such as visual color distortions. This information is derived from comprehensive clinical trial data.

Q: Can Powerman be taken with food, or does it need to be on an empty stomach?

Regulatory documents state that for the IEF regimen, the medicine may be taken with or without food. However, studies indicate that taking the medicine with a high-fat meal can delay the rate at which the active ingredient is absorbed. This delay may affect the time it takes for the medicine to start working.

Q: Are there special warnings for women using Powerman?

Powerman is not indicated for the treatment of Impaired Erectile Function in women. For the PAH indication, while the medicine is prescribed, regulatory labels note that no adequate and well-controlled studies exist in pregnant women. Because of this, the official guidance requires a careful risk assessment when prescribing the medicine during pregnancy or lactation.

Q: Is there a generic version of Powerman available yet?

Yes, the active ingredient in Powerman is Sildenafil. This compound has been approved by regulatory bodies as a generic equivalent and is manufactured by various pharmaceutical companies in compliance with regulatory standards.

Q: How quickly does Powerman leave your system after you stop taking it?

Official pharmacokinetics data indicates that the active ingredient has a terminal half-life of approximately 3 to 5 hours. This is the time it takes for half the dose to be cleared from the blood. The medicine's clearance kinetics are described by this half-life.

Q: Does taking Powerman affect my sleep?

The official safety profile includes reports of sleep-related side effects. Insomnia (difficulty sleeping) is listed as a Common adverse reaction. Restless sleep has also been reported among the less common side effects documented in official safety profiles.

Q: What types of doctors usually prescribe Powerman?

Powerman is a prescription-only medicine used to treat specific conditions. It is typically prescribed by medical professionals specializing in those fields, such as urologists for Impaired Erectile Function or cardiologists and pulmonologists for Pulmonary Arterial Hypertension.

Q: How is Powerman different from other drugs in the same class?

The active ingredient, Sildenafil, has a specific dosing regimen, rate of clearance, and duration of action that distinguishes it from other compounds in the PDE5 inhibitor class. These details are outlined in the official regulatory label for the medicine.

Q: Does taking Powerman make you feel different emotionally?

According to regulatory safety documents, Anxiety is listed as a Common side effect (1% to 10% of patients). Mental depression has been reported among the rare side effects documented in official post-marketing reports.

Q: What should I do if I feel like Powerman isn't working for me?

For the IEF regimen, regulatory prescribing information states that the dose may be adjusted based on efficacy and tolerability up to a maximum single dose. If expectations are not being met, consulting a healthcare provider for a review of the conditions of use or the current dose is recommended by prescribing guidance.

Q: Where can I find the official regulatory information about Powerman?

Official product information, which includes all legally required details, is available through government-maintained drug databases. These sources include the NIH DailyMed Prescribing Information or the product’s FDA Label or EMA Summary of Product Characteristics (SmPC).

Q: Why do doctors monitor certain lab tests while a person is taking Powerman?

Dose adjustments are required for people with severe renal (kidney) impairment or hepatic (liver) impairment because these conditions can reduce the medicine's clearance. Monitoring kidney and liver function tests may be done to assess if a special dosage is needed.

Q: Has Powerman been studied in children or teenagers?

Yes, studies have examined the medicine for the treatment of Pulmonary Arterial Hypertension (PAH) in pediatric patients aged 1 to 17. However, chronic use with rising doses in this population carries a regulatory warning and is not recommended in the official prescribing information, based on clinical findings of increased mortality observed in a specific trial.

Q: What are the main findings from the clinical trials for Powerman?

The initial trials focused on specific outcomes. IEF trials showed improvement in patient-reported outcomes, such as the percentage of successful sexual attempts. PAH trials showed improvement in exercise capacity, measured by the 6-minute walk distance (6MWD).

Q: Is the research for Powerman considered strong?

The initial efficacy and safety were established primarily through short-term Randomized, Double-Blind, Placebo-Controlled Trials (RCTs). This type of research structure (RCTs) is considered the gold standard for establishing initial efficacy and safety and forms the primary evidence base.

Q: What if Powerman is expired?

Regulatory instructions strictly mandate that unused or expired tablets should be discarded immediately using a community drug take-back program. The medicine should not be disposed of via wastewater (such as flushing down the toilet). Regulatory guidance requires disposal through community drug take-back programs.

Q: How long does it usually take to start noticing an effect from Powerman?

Clinical data shows the medicine’s concentration in the blood typically peaks around 60 minutes (with a range of 30 to 120 minutes) after dosing. The IEF regimen is intended to be taken within a window of 30 minutes to 4 hours before anticipated activity.

Q: What happens if Powerman is taken with alcohol?

Both the medicine and alcohol can lower blood pressure. Official warnings state that taking them together may increase the risk of hypotensive side effects, such as dizziness, light-headedness, and headache, due to an additive blood pressure-lowering effect. Because of this risk of additive side effects, regulatory guidance suggests limiting consumption.

Q: Is Powerman appropriate for people over the age of 65?

For the IEF regimen, regulatory guidance states that a starting dose of 25 mg should be considered for older adults (ge 65 years). This adjustment is a precautionary step to account for the expected increase in the drug’s systemic exposure in older adults.

Q: What medical conditions prevent someone from using Powerman?

The medicine is strictly contraindicated if a person is taking medications like organic nitrates or riociguat. It is also prohibited for those with a history of NAION (sudden vision loss) or certain severe cardiovascular conditions (e.g., recent stroke or heart attack within six months).

Q: Does Powerman interact with common pain relievers like ibuprofen?

The official interaction profile details constraints for specific drug classes, such as CYP3A4 inhibitors and anti-hypertensives. Regulatory documents do not consistently report a specific interaction between Sildenafil and common non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen in standard checkers.

Q: Can Powerman be used long-term?

While efficacy was maintained in some long-term (1-year) open-label studies for IEF, there are limitations in the controlled evidence regarding the long-term effects of use over multiple years. Chronic use with rising doses in pediatric PAH patients carries a regulatory warning and is specifically not recommended.

Q: Are there any foods I absolutely must avoid while on Powerman?

Regulatory information advises limiting or avoiding consumption of substances that inhibit the CYP3A4 enzyme, which clears the medicine from the body. For this reason, regulatory information advises limiting or avoiding consumption of substances, such as grapefruit or grapefruit juice, which can increase the medicine’s level in the body.

Q: Does Powerman have an effect on blood pressure?

Yes, official pharmacodynamic data confirms that Sildenafil has systemic vasodilatory effects. This action is documented to cause a transient decrease in both systolic and diastolic blood pressure in healthy volunteers.

Q: Why do some people experience stomach upset with Powerman?

The official product information lists Dyspepsia (stomach upset) as a Common side effect. This is thought to be related to the medicine’s mechanism of action affecting smooth muscle relaxation in the gastrointestinal tract, which can potentially lead to discomfort or feelings of early fullness.

How should Powerman be stored and disposed of?

How to Store and Dispose of Powerman

The storage and disposal of Sildenafil (Powerman) must adhere strictly to regulatory requirements to ensure product stability and safety.

Storage Requirements

Sildenafil tablets must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), with permitted fluctuations up to 30 C. The medicine must be kept in its original container, which should be kept tightly closed to protect the solid tablets. A mandatory regulatory requirement is to store the medicine out of the sight and reach of children.

Disposal Instructions

Unused or expired tablets should be discarded according to local pharmaceutical regulations. The preferred method is using a community drug take-back program. The product must not be disposed of via wastewater (such as flushing down the toilet).

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Powerman found in:

A-Z Index: